Ann: SPL7013 nasal spray for COVID19 development update, page-71

First 71 Last

Share
Profile

Follow
Edny

47 Posts.

9

26/08/20

12:15

Post #: 46829564
Share

Originally posted by ajk92: ↑

I have not been active on this SPL thread for quite some time due to the repetitive nature of discussion and lack of meaningful execution from management.

Still holding the stock and still big on the science - I however have no faith in Jackie's ability to take this product to market. If they licence it to someone like Sanofi, or better yet Johnson & Johnson (as they have a massive OTC product range), with associated regulatory approvals, this will take off.

Today is more pivotal than yesterday, if this kicks on and goes up rather than pulling back as it usually does after an announcement, the market may actually like this news. Could test 12 month highs or even the highs since I've held it (I think it touched $1.66 on one fine day).

Any real updates from the Dep trials with response rates and/or additional Dep licenses with payments would be great.

Big believer in SPL, but its been a very long wait, and will probably still be a while until it reaches its potential.

But happy to wait for it.

Expand

Hey, ajk92, I agree with you about the next trading day or two being pivotal. On the US market earlier today, SPHRY (the SPL ADR) was up 22%, in line with SPL on the ASX yesterday. The volume was not nearly as high though, about 8000 ADRs (80,000 SPL shares). Make what you will of that...

SPL Price at posting: $1.36 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RBA holds rates as ALP election campaigning kicks off – expect more political focus

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

There are more pages in this discussion • 82 more messages in this thread...

First 71 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 10.0¢		Change 0.002(1.53%)		Mkt cap ! $41.60M

Open	High	Low	Value	Volume
9.8¢	10.0¢	9.7¢	$30.53K	310.4K

Buyers (Bids)

No.	Vol.	Price($)
1	82	9.9¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	223100	7

View Market Depth

No.	Vol.	Price($)
1	82	0.099
1	245200	0.098
1	68758	0.097
1	824859	0.095
2	72280	0.092

Price($)	Vol.	No.
0.100	223100	7
0.105	199684	6
0.110	203882	6
0.115	103392	3
0.120	112305	4

Last trade - 14.33pm 05/11/2024 (20 minute delay)

SPL (ASX) Chart

Ann: SPL7013 nasal spray for COVID19 development update, page-71

RBA holds rates as ALP election campaigning kicks off – expect more political focus

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: SPL7013 nasal spray for COVID19 development update, page-71

Top Stories

RBA holds rates as ALP election campaigning kicks off – expect more political focus

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News